NCT01675778View on ClinicalTrials.gov

Association Between Body Size and Response to Hydromorphone in ED

PHASE2CompletedINTERVENTIONAL
Enrollment

174

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions
Pain
Interventions
DRUG

Hydromorphone

a fixed dose (1 mg) of hydromorphone will be given to the study subjects

Trial Locations (2)

10461

Jacobi Medical Center, The Bronx

10467

North Central Bronx Hospital, The Bronx

All Listed Sponsors
lead

Albert Einstein College of Medicine

OTHER

NCT01675778 - Association Between Body Size and Response to Hydromorphone in ED | Biotech Hunter | Biotech Hunter